Abstract
e15136Background: The role of granulocyte-colony stimulating factor (G-CSF) agents for patients undergoing oxaliplatin-based adjuvant therapy for stage III colon cancer has not been assessed. We so...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have